Mupirocin and Staphylococcus aureus: A recent paradigm of emerging antibiotic resistance

Journal of Antimicrobial Chemotherapy

Volumn 51, Issue 3, 2003, Pages 613-617

  Upton, Arlo ^a   Lang, S ^b   Heffernan, H ^c  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b MIDDLEMORE HOSPITAL   (New Zealand)

^c INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

Author keywords

Mupirocin; Resistance; Staphylococcus aureus

Indexed keywords

METICILLIN; NON PRESCRIPTION DRUG; PSEUDOMONIC ACID;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG USE; GEOGRAPHICAL VARIATION (SPECIES); HEALTH SURVEY; HOSPITAL; INFORMATION PROCESSING; LABORATORY TEST; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NEW ZEALAND; NONHUMAN; STAPHYLOCOCCUS AUREUS;

COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; HEALTH SURVEYS; HUMANS; MUPIROCIN; NEW ZEALAND; STAPHYLOCOCCUS AUREUS;

EID: 0037343010     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg127     Document Type: Article

References (23)

1. Sutherland, R., Boon, R. J., Griffin, K. E., Masters, P. J., Slocombe, B. & White, A. R. (1985). Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use. Antimicrobial Agents and Chemotherapy 27, 495-8.
2. Fernandez, C., Gaspar, C., Torrellas, A., Vindel, A., Saez-Nieto, J. A., Crutet, F. et al. (1995). A double-blind, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of mupirocin calcium ointment for eliminating nasal carriage of Staphylococcus aureus among hospital personnel. Journal of Antimicrobial Chemotherapy 35, 399-408.
3. Redhead, R. J., Lamb, Y. J. & Rowsell, R. B. (1991). The efficacy of calcium mupirocin in the eradication of nasal Staphylococcus aureus carriage. British Journal of Clinical Practice 45, 252-4.
4. Cimochowski, G. E., Harostock, M. D., Brown, R., Bernardi, M., Alonzo, N. & Coyle, K (2001). Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics. Annals of Thoracic Surgery 71, 1572-8.
5. Sesso, R., Barbosa, D., Leme, I. L., Sader, H., Canziani, M. E., Manfredi, S. et al. (1998). Staphylococcus aureus prophylaxis in haemodialysis patients using central venous catheter: effect of mupirocin ointment. Journal of the American Society of Nephrology 9, 1085-92.
6. Thodis, E., Bhaskaran, S., Pasadakis, P., Bargman, J. M., Vas, S. I. & Oreopoulos, D. G. (1998). Decrease in Staphylococcus eureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter site. Peritoneal Dialysis International 18, 261-70.
7. Farmer, T. H., Gilbart, J. & Elson, S. W. (1992). Biochemical basis of mupirocin resistance in strains of Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 30, 587-96.
8. Casewell, M. W. & Hill, R. L. (1985). In-vitro activity of mupirocin ('pseudomonic acid') against clinical isolates of Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 15, 523-31.
9. Gilbart, J., Perry, C. R. & Slocombe, B. (1993). High-level mupirocin resistance in Staphylococcus aureus: evidence for two distinct isoleucyl-tRNA synthetases. Antimicrobial Agents and Chemotherapy 37, 32-8.
10. Andrews, J. M. (2001). BSAC standardized disc susceptibility testing method. Journal of Antimicrobial Chemotherapy 48, Suppl. S1, 43-57.
11. Harbath, S., Dharan, S., Liassine, N., Herrault, P., Auckenthaler, R. & Pittet, D. (1999). Randomised, placebo-controlled, double-blinded trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 43, 1412-6.
12. Rahman, M., Noble, W. C. & Cookson, B. (1987). Mupirocin-resistant Staphylococcus aureus. Lancet ii, 387-8.
13. Moorhouse, E., Fenelon, L., Hone, R., Smyth, E., McGahon, J. & Dillon, M. (1996). Staphylococcus aureus sensitivity to various antibiotics - a national survey of Ireland 1993. Irish Journal of Medical Science 165, 40-3.
14. Schmitz, F., Lindenlauf, E., Hofmann, B., Fluit, A. C., Verhoef, F., Heinz, H. et al. (1998). The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals. Journal of Antimicrobial Chemotherapy 42, 489-95.
15. Vasquez, J. E., Walker, E. S., Franzus, B. W., Overbay, B. K., Reagan, D. R. & Sarubbi, F. A. (2000). The epidemiology of mupirocin resistance among methicillin-resistant Staphylococcus aureus at a veterans' affairs hospital. Infection Control and Hospital Epidemiology 21, 459-64.
16. Nettos dos Santos, K. R., de Souza Fonseca, L. & Filho, P. (1996). Emergence of high-level mupirocin resistance in methicillin-resistant Staphylococcus aureus isolated from Brazilian University hospitals. Infection Control and Hospital Epidemiology 17, 813-6.
17. Chang, N. & Chui, L. (1998). A standardized protocol for the rapid preparation of bacterial DNA for pulsed-field gel electrophoresis. Diagnostic Microbiology and Infectious Disease 31, 275-9.
18. Skellem, P., Toy, G. & Lang, S. (1998). Staphylococcus aureus highly resistant to mupirocin is now common in Auckland. New Zealand Medical Journal 111, 82.
19. Riley, T. V., Carson, C. F., Bowman, R. A., Mulgrave, L., Golledge, C. L., Pearman, J. W. et al. (1999). Mupirocin-resistant methicillin-resistant Staphylococcus aureus in Western Australia. Medical Journal of Australia 161, 397-8.
20. Torvaldsen, S., Roberts, C. & Riley, T. V. (1999). The continuing evolution of methicillin-resistant Staphylococcurs aureus in Western Australia. Infection Control and Hospital Epidemiology 20, 133-5.
21. Harbath, S., Liassine, N., Dharan, S., Herrault, P., Auckenthaler, R. & Pitter, D. (2000). Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus infections. New England Journal of Medicine 346, 1871-7.
22. Perl, D M., Cullen, J. J., Wenzel, R. P., Zimmerman, M. B., Pfaller, M. A., Sheppard, D. et al. (2002). Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. New England Journal of Medicine 346, 1781-7.
23. Christensen, O. B. & Anehus, S. (1994). Hydrogen peroxide cream: an alternative to topical antibiotics in the treatment of impetigo contagiosa. Acta Dermatovenereologica (Supplementum) 74, 460-2.